Church W R, Bhushan F H, Mann K G, Bovill E G
Department of Biochemistry, College of Medicine, University of Vermont, Burlington 05405.
Blood. 1989 Nov 15;74(7):2418-25.
Vitamin K deficiency or administration of vitamin K antagonists results in the biosynthesis of abnormal des-gamma-carboxy forms of the vitamin K-dependent proteins. Monoclonal antibody H-11 binds several vitamin K-dependent proteins at a determinant that includes the first two residues of gamma-carboxyglutamic acid. Antibody H-11 binds fully carboxylated prothrombin and protein C in the presence of EDTA but binding is inhibited by the divalent metal ions, calcium, magnesium, and manganese. By contrast, des-gamma-carboxy prothrombin and protein C bind antibody H-11 the same in the presence of EDTA or calcium ion. Antibody H-11 thus appears to bind a conserved antigenic site containing gamma-carboxyglutamic acid that in the presence of divalent metal ion undergoes a conformational transition. This ability of antibody H-11 to bind des-gamma-carboxy prothrombin and protein C in the presence of calcium ion allowed the development of an immunoassay for these proteins in plasma. Prothrombin and protein C from stably anticoagulated individuals receiving warfarin were characterized by their ability to bind antibody H-11 in the presence of calcium ion. Binding of prothrombin and protein C to antibody H-11 in the presence of calcium correlated temporally with warfarin administration. The inability of calcium ion to inhibit binding of antibody H-11 to abnormal prothrombin and protein C in plasma suggests that the circulating forms of both proteins following warfarin administration cannot undergo the metal ion-dependent conformational transition that includes sequence residues 1 through 12.
维生素K缺乏或使用维生素K拮抗剂会导致维生素K依赖性蛋白的异常去γ-羧基形式的生物合成。单克隆抗体H-11在一个决定簇处结合几种维生素K依赖性蛋白,该决定簇包括γ-羧基谷氨酸的前两个残基。在存在乙二胺四乙酸(EDTA)的情况下,抗体H-11能结合完全羧化的凝血酶原和蛋白C,但二价金属离子钙、镁和锰会抑制这种结合。相比之下,在存在EDTA或钙离子的情况下,去γ-羧基凝血酶原和蛋白C与抗体H-11的结合情况相同。因此,抗体H-11似乎结合了一个包含γ-羧基谷氨酸的保守抗原位点,该位点在二价金属离子存在时会发生构象转变。抗体H-11在钙离子存在下结合去γ-羧基凝血酶原和蛋白C的这种能力使得能够开发一种针对血浆中这些蛋白的免疫测定方法。接受华法林治疗的稳定抗凝个体的凝血酶原和蛋白C通过它们在钙离子存在下结合抗体H-11的能力来表征。凝血酶原和蛋白C在钙离子存在下与抗体H-11的结合在时间上与华法林的给药相关。钙离子无法抑制抗体H-11与血浆中异常凝血酶原和蛋白C的结合,这表明华法林给药后这两种蛋白的循环形式无法经历包括第1至12个序列残基的金属离子依赖性构象转变。